DIRECTOR DEALINGS: Hikma Non-Executive Director Buys First Shares

Tue, 12th Apr 2016 09:48

LONDON (Alliance News) - Hikma Pharmaceuticals PLC Tuesday said Non-Executive Director John Castellani bought 2,500 shares at 2,103 pence each on Monday.

The purchase is Castellani's only holding in the FTSE 250 company after being appointed in February. He was president and chief executive officer of the Pharmaceutical Research & Manufacturers of America from 2010 to 2015.

Shares in the Jordan-founded drug maker were up 0.1% at 2,145.00p Tuesday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Related Shares

More News

11 Jun 2024 09:57

LONDON BROKER RATINGS: Morgan Stanley cuts Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

11 Jun 2024 08:45

Citi hikes Hikma price target, cites 'healthy trends' for injectables and US Generics

(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "hea...

3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

26 Apr 2024 13:36

UK dividends calendar - next 7 days

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

Latest Share Chat